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Abstract
Quetiapine is an atypical antipsychotic drug that can be used to treat mental disorders, including schizophrenia, bipolar disorder and Alzheimer's disease. Quetiapine is mainly converted into the active metabolites of norquetiapine and
7-hydroxyquetiapine by the liver enzymes CYP3A4 and CYP2D6. In this study, liquid-liquid extraction (LLE) was used
as a sample pretreatment method to eliminate interferences in plasma. tert-Butyl methyl ether was chosen as the
extraction solvent. Field-enhanced sample injection (FESS), an online preconcentration technique, was used to analyze
quetiapine and its metabolites norquetiapine and 7-hydroxyquetiapine in plasma. The optimal separation condition was
120 mM phosphate (pH 4.0) containing 0.005% (w/v) polyvinyl pyrrolidone and 40% (v/v) methanol. The methanol plug
was 0.3 psi for 6 s, the sample was electrokinetic injection by 10 kV for 60 s at positive polarity, and the separation
voltage was set at 26 kV. In this experiment, quetiapine, norquetiapine and 7-hydroxyquetiapine were successfully
extracted from plasma by the LLE method and stacking and separated by FESS within 15 min. The limits of detection (S/
N ¼ 3) of quetiapine, norquetiapine and 7-hydroxyquetiapine were 0.25 ng/mL, 0.50 ng/mL and 1.00 ng/mL, respectively.
The linear ranges of quetiapine, norquetiapine and 7-hydroxyquetiapine were 3e120 ng/mL and the correlation coefﬁcients were 0.999. Compared with that of the traditional capillary zone electrophoresis method, the sensitivity
enrichment of analytes was 463-835-fold. The optimal experimental conditions were successfully applied to the analysis
of plasma samples from patients taking quetiapine for the treatment of schizophrenia.
Keywords: Field-enhanced sample stacking, Liquid-liquid extraction, Metabolites, Plasma, Quetiapine

1. Introduction

Q

uetiapine (QTP), 2-[2-(4-dibenzo [b, f] [1, 4]
thiazepin-11-yl-1-piperazinyl) ethoxy] ethan
ol, is a dibenzothiazepine derivative and a
second-generation antipsychotic agent that is used
to treat schizophrenia [1]. The mechanism of QTP is
still unknown. However, preclinical research has
shown that QTP exhibits antagonistic action on
several receptors, such as serotonin 5-HT1A and 5HT2, dopamine D1 and D2, histamine H1 and
adrenergic a1 and a2 receptors [2]. QTP is metabolized by the liver, including hydroxylation,

oxidation, dealkylation and sulfoxidation and produces more than 20 metabolites. The main metabolic pathways of QTP are shown in Fig. S1. QTP is
metabolized to norquetiapine (NorQTP), quetiapine
sulfoxide and 7-hydroxyquetiapine (7-QTP) via isoenzymes CYP3A4 and CYP2D6. NorQTP and 7-QTP
are active metabolites [3,4]. NorQTP has moderate
antagonism with 5-HT2 and dopamine D2 receptors
[5]. Moreover, NorQTP can effectively inhibit
norepinephrine transport in combination with
norepinephrine. Insufﬁcient concentrations of
norepinephrine in the synaptic cleft may lead to
depression. Therefore, blocking norepinephrine
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transport to prevent reuptake of norepinephrine can
increase the concentration of norepinephrine in the
synaptic cleft, which is the main mechanism to treat
depression in bipolar disorder [6]. The metabolic
half-life (t1/2) of QTP is 6 h, NorQTP is approximately 9e12 h, and for 7-QTP, it is has a very similar
to QTP [7,8].
In a previous study, Mandrioli and Fanali et al.
combined high-performance liquid chromatography (HPLC) with a UV detector to determine QTP
in human plasma, and the LOD for this technique
was 1.5 ng/mL [9]. In addition, Pucci and Mandrioli
et al. detected QTP in pharmaceuticals by capillary
electrophoresis (CE) with a UV detector. QTP was
observed within 2 min in this capillary zone electrophoretic (CZE) mode, and the LOD for this
technique was 50 ng/mL [10]. Compared with other
analytical methods, the advantages of CE methods
include few samples and solvent consumption, high
separation efﬁcacy and low cost of operating the
instrument. However, unlike common HPLC measurements, low detection sensitivity was a disadvantage of CE. Therefore, capillary electrophoresis
was combined with an online preconcentration
technique for improving the detection sensitivity to
estimate the concentration of QTP and its metabolites, NorQTP and 7-QTP, in human plasma.
In this study, an online preconcentration technique, ﬁeld-enhanced sample stacking (FESS), was
chosen to detect QTP and its metabolites in plasma
to improve the detection sensitivity. The pKa values
of QTP and its metabolites, NorQTP and 7-QTP,
were 7.06, 8.83 and 7.06, respectively [11]. Hence, the
analytes are positively charged in acidic environments. The sample stayed in a low conductivity
solution and the background solution (BGS) was a
high conductivity environment. When a high
voltage was applied, the analytes move to cathode
and stacked at the boundary of the sample solution
and BGS by FESS [12,13]. Then, the analytes were
separated by capillary zone electrophoresis.

hydroxide (30%) was purchased from J. T. Baker
(Phillipsburg, NJ, USA). tert-Butyl methyl ether was
purchased from Alfa Aesar (Ward Hill, MA, USA).
Disodium hydrogen phosphate dehydrate (Na2HPO4$2H2O), hydrochloric acid and sodium hydroxide were purchased from Merck (Darmstadt,
Germany). The buffer and related aqueous solutions
were prepared with deionized distilled water that
was obtained with a Milli-Q System from Millipore
(Bedford, MA, USA). The solutions were ﬁltered
through a 0.45 mm nylon ﬁlter from Jet Bio-Filtration
(Guangzhou, China) prior to use. The QTP, NorQTP
and 7-QTP were prepared in methanol at a concentration of 1 mg mL1 and stored at 20  C.
2.2. CE conditions
In this study, the CE apparatus was a P/ACE™
MDQ series capillary electrophoresis system
equipped with a photodiode array (PDA) detector
(Beckman Coulter Inc., Fullerton, CA, USA). The
apparatus operation, electropherogram acquisition,
and data organization were controlled using the
Beckman Coulter 32-Karat software system (Fullerton). Uncoated fused silica capillaries (50 mm I.D.)
were obtained from Polymicro Technologies
(Phoenix, AZ, USA); the total capillary length was
50 cm, and the distance to the detector was 40 cm in
the CE procedure. After each experimental run, the
capillary was rinsed with hydrochloric acid (3 min)
and deionized distilled water (3 min) at 30 psi. The
BGS was 120 mM phosphate (pH 4.0) containing
0.005% (w/v) PVP and 40% (v/v) methanol. The
methanol plug was 0.3 psi for 6 s, and it was hydrodynamically injected before the sample injection. The sample was injected electrokinetically at a
positive voltage of 10 kV for 60 s, and a separation
voltage of 26 kV was applied. The UV detector was
set at 214 nm, and the temperature of separation
was kept at 20  C.
2.3. Sample preparation

2. Materials and methods
2.1. Chemicals and reagents
All chemicals and reagents were analytical grade.
Quetiapine fumarate (QTP), norquetiapine hydrochloride (NorQTP) and 7-hydroxyquetiapine (7QTP) were purchased from Sigma-Aldrich (TX,
USA). Polyvinyl pyrrolidone (PVP) (Mw 1,300,000)
and 4-aminopyridine (as internal standards) purchased from Sigma-Aldrich (St. Louis, MO, USA).
Methanol was purchased from Macron Fine
Chemicals (Center Valley, PA, USA). Ammonium

Plasma samples were collected from patients
taking QTP for the treatment of schizophrenia and
were stored at 20  C. (This study was approved by
the Institutional Review Board (KMUHIRB-F(I)20190014) at Kaohsiung Medical University,
Taiwan). Liquid-liquid extraction was performed to
eliminate interference present in the plasma. A
500 mL aliquot of each plasma sample was spiked
with 70 mL 1 M ammonium hydroxide solution in a
2-mL microcentrifuge tube and extracted with
1000 mL tert-butyl methyl ether by vortexing for
3 min. After centrifugation at 12000 rpm for 10 min,

2.4. Nano-UPLC-MS/MS analysis and conditions
A nanoACQUITY UPLC system (Waters, MA,
USA) was coupled with an LTQ orbitrap discovery
hybrid Fourier transform mass spectrometer
(Thermo Fisher Scientiﬁc, Inc. Bremen, Germany)
equipped with a nanoelectrospray positive ionization (nano ESI) interface. The desalting column was
equipped with a symmetric C18 column (5 mm,
180 mm  20 mm), and the analytical column was
equipped with a BEH C18 column (1.7 mm,
75 mm  150 mm). The mobile phase included 0.1%
formic acid as solvent A and acetonitrile containing
0.1% formic acid as solvent B. The sample loading
volume was 2 mL. The initial gradient elution conditions were solvent B at 1%, then conditions were
adjusted to 100% after 5 min and maintained in
isocratic mode for 45 min. Finally, solvent B was
adjusted to 1% after 60 min. The ﬂow rate was set at
300 nL min1. Each plasma sample was pretreated
and then analyzed with nano-UPLC-MS in positive
ionization mode with MRM mode to identify the
QTP at 384.17 (m/z), NorQTP at 296.12 (m/z) and 7QTP at 400.16 (m/z).

3. Results and discussions
3.1. Sample pretreatment
In this study, the samples were pretreated with a
liquid-liquid extraction (LLE) to concentrate and
purify three targets, QTP, NorQTP and 7-QTP, and
eliminate interferences in plasma. To obtain the
optimal extraction conditions, several parameters
were evaluated, including plasma pH values,
extraction solvents and extraction solvent volumes.
3.1.1. Plasma pH
The pKa values of QTP and its metabolites,
NorQTP and 7-QTP, were 7.06, 8.83 and 7.06,
respectively. When the pH value of plasma is more
than 10.83, QTP and its metabolites are present
primarily in their uncharged forms, which means
that it is easier to extract them in the organic layer.
Four pH values of plasma were selected, pH 8.0, pH
9.0, pH 10.0, and pH 11.0, to evaluate the extraction
efﬁciency. The three analytes can be successfully
extracted under these four pH conditions. Their

relative response was determined by comparing the
ratio of the maximum peak areas of the analytes
with the peak area of the internal standard, which
was deﬁned as 100%. As the pH values of plasma
increased, the peak areas of QTP and NorQTP
increased slightly. Fig. S2 shows that the relative
response of 7-QTP at pH 11.0 was lower than that at
pH 10.0. When the pH value of plasma is more than
10.48, the phenol group of 7-QTP (pKa value is 8.48)
completely dissociates into a negatively charged
form, which leads to low extraction efﬁciency.
Hence, the optimal pH value of plasma was 10.0.
3.1.2. Extraction solvents
The log P values of QTP, NorQTP and 7-QTP were
2.81, 3.16 and 2.33, respectively, [14]. Therefore,
medium- and low-polarity organic solvents were
chosen for evaluating the extraction effect. In this
study, four organic solvents with different polarities,
ethyl acetate, chloroform, dichloromethane and tertbutyl methyl ether, were tested.
The log P values of the four extraction solvents
are:
chloroform
(1.97)
>
dichloromethane
(1.25) > tert-butyl methyl ether (0.94) > ethyl acetate
(0.73) [14]. According to the electropherograms, all
four solvents successfully extracted the three analytes. The extraction efﬁciency results shown in
Fig. 1. Dichloromethane and tert-butyl methyl ether
had a better extraction effect than the other two
solvents. However, the densities of dichloromethane
and chloroform were greater than that of plasma,
which made it difﬁcult to collect the extraction
phase. In addition, an emulsion formed at the
interface between plasma and two extraction

Relative response (%)

850 mL of the organic supernatant was separated and
evaporated to dryness via a centrifugal vaporizer
(EYELA UT-1000, Japan). The dried extracts were
reconstituted with 100 mL 20 ng mL-1 internal standard and ﬁltered through a nylon ﬁlter prior to CE
analysis.

Extraction solvent

Fig. 1. Effect of different extraction solvents in LLE procedure. Analytes
concentrations: NorQTP: 50 ng/mL, QTP: 50 ng/mL, 7-QTP: 50 ng/mL.
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solvents, which decreased the available volume of
solvent. The extraction recoveries of different
extraction solvents are summarized in Table S1. The
extraction recoveries of tert-Butyl methyl ether were
55.3%, 20.57% and 52.9% for QTP, NorQTP and 7QTP, respectively. Finally, tert-Butyl methyl ether
was selected as the optimal extraction solvent.
3.1.3. Solvent volume
To assess the effect of extract solvent volume, four
different volume of tert-butyl methyl ether (500 mL,
750 mL, 1000 mL and 1250 mL) were analyzed and
extraction recoveries are shown in Table S2. The
extraction recoveries increased as the solvent volume increased from 500 mL to 1000 mL, and then
decreased for 1250 mL. This may be because more
matrix in the plasma was extracted in the highest
solvent volume (1250 mL) and the matrix substrates
compete with analytes during electrokinetic injection leading to the capillary. Hence, the optimal
volume of tert-butyl methyl ether was set as 1000 mL.
3.2. Separation conditions of CE
3.2.1. Buffer pH
According to the pKa values of QTP (7.06),
NorQTP (8.83) and 7-QTP (7.06), the analytes are
weakly alkaline compounds. 4-Aminopyridine was
as internal standard with pKa 9.17 and log P 0.32
[11,14]. Thus, a weakly acidic buffer was selected
since the analytes were positively charged during
the analysis. Four pH values of 120 mM phosphate
buffer, pH 3.0, pH 3.5, pH 4.0, and pH 5.0, were
studied. The electropherograms are shown in
Fig. S3. The results show that QTP and 7-QTP
could not be separated in 120 mM phosphate
buffer at pH 3.0 and pH 3.5. At pH 4.0 and pH 5.0,
the three analytes were completely separated.
When the pH value is higher, the analytes moves
more slowly. The reason is that the chargeability of
the analytes was weaker and the electrophoretic
mobility of analytes were smaller at higher pH.
Considering the analysis time and separating efﬁciency, the pH 4.0 phosphate buffer was chosen as
optimal condition.
3.2.2. Methanol proportion in BGS
Adding methanol to phosphate buffer could
effectively reduce the polarity of BGS and EOF
[15,16]. Hence, methanol was proposed to improve
the separation and accumulation of analytes in this
study and four different proportions of methanol
(0%, 20%, 30%, 35%, 40% (v/v)) were investigated.
The electropherograms are shown in Fig. 2. Three
peaks could not stack when there was no methanol

or only 20% methanol in the BGS. Because of the
larger EOF, it was not possible to accumulate the
analytes at boundary of sample zone and BGS. With
30% or more methanol in the phosphate buffer, the
polarity of BGS and EOF were effectively reduced
[15,16], and the three analytes gradually stacked into
sharp peaks. However, a high proportion of methanol (such as 50% methanol) in the solution can
more easily cause volatilization, which leads to a
dramatic change in the ratio of the buffer over time
and causes poor reproducibility. With 50% organic
solvent, the pH value of BGS may be 1e1.5 units
higher than the measured pH [17]. The addition of
methanol to BGS may increase the pH and suppress
the ionization of analytes. In this study, all analytes
still exhibited a positive charge when 40% (v/v)
methanol was added to BGS. When the methanol
ratio was increased to 40% (v/v), the three analytes
could be fully separated. It was indicated that 40%
(v/v) methanol was the optimal condition.
3.2.3. Polymers
Analytes were cations under acidic conditions,
which can easily adsorb on the capillary wall and
cause poor reproducibility. Adding polymers to the
buffer can dynamically attach to the SiO adsorption sites on the capillary wall to improve the
reproducibility [18,19]. Three polymers, 0.005% (w/
v) hydroxyethyl cellulose (HEC) (Mw: 250,000),
0.005% (w/v) polyvinyl alcohol (PVA) (Mw:
31,000e50,000) and 0.005% (w/v) polyvinyl pyrrolidone (PVP) (Mw: 1, 3000, 000), were selected in this
experiment. Among them, PVA exhibited poor solubility and it was necessary to heat to increase its
solubility. PVP had better solubility than HEC [20].
Hence, PVP was selected in this study.
To evaluate the effect of different concentrations
of PVP in BGS for reproducibility and separation
efﬁciency, four concentrations of PVP were selected:
0%, 0.001%, 0.005% and 0.01% (w/v). The electropherograms are shown in Fig. S4 and these four
concentrations of PVP in BGS were not affect the
separation efﬁciency. At 0% PVP in BGS, the peak
area of the analytes showed a signiﬁcant deviation
in three repeatability tests (n ¼ 3), and the RSD
values of the peak areas were all greater than 29%.
This illustrated that without PVP in BGS, the partial
analytes were adsorbed on the capillary wall. According to the results, it is indicated that a small
amount of PVP in the separation buffer can avoid
the adsorption of the analytes on the capillary wall.
However, 0.01% PVP increases the viscosity of the
solution, which causes poor resolution of the 7-QTP
and blank peak. Thus, the optimal condition was set
as 0.005% (w/v) PVP in BGS.
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Fig. 2. Electropherograms of different methanol proportion in BGS. (a) 0%, (b) 20%, (c) 30%, (d) 35%, (e) 40%. Analytes concentrations: peak 1:
NorQTP (50 ng/mL), peak 2: QTP (50 ng/mL), peak 3: 7-QTP (50 ng/mL). CE condition: separation buffer, 120 mM phosphate (pH 4.0) containing
0.005% (w/v) PVP and methanol; methanol plug: 0.3 psi, 6 s; sample injection, þ10 kV, 60 s; separation voltage, þ26 kV; detection wavelength,
214 nm; temperature: 20  C.

3.2.4. The effect different kinds of plugs
The principle of FESS was to initially rinse the
capillary with the high-conductivity separation buffer
and then inject a low-conductivity solvent plug. After
applying a high voltage across the capillary, the analytes moved from a low-conductivity, fast-moving
environment to a high-conductivity, slow-moving
environment. Then, the analytes accumulated at interfaces that can improve the sensitivity of this assay
[18]. In this study, the experiment was evaluated
without a plug and injecting three solvent plugs
(water, acetonitrile, and methanol). The conductivities
of the phosphate buffer (120 mM phosphate (pH 4.0)
containing 0.005% PVP and 40% (v/v) methanol),
water, acetonitrile, and methanol plug were 2.62 mS,
0.6 mS, 0.0 mS, and 0.0 mS, respectively. The electropherograms are shown in Fig. S5. Three analytes can

be separated under all the above conditions. A better
stacking effect was obtained with the methanol plug
than others. The conductivities of acetonitrile and
methanol were the same; however, the viscosity of
methanol was higher than that of acetonitrile. This
causes the stacking efﬁciency to be better with a
methanol plug than an acetonitrile plug. Among the
candidates, a methanol plug was selected as the
optimal condition.
3.2.5. The effect of sample injection time
In this study, the electrokinetic injection method
was used to evaluate the inﬂuence of injection volume on peak area and migration time of analytes.
The injection voltage was set at 10 kV with a positive
voltage, four different injection times (50 s, 60 s, 70 s,
and 80 s) were compared. The electropherograms
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are shown in Fig. S6. When the sample injection
time was longer, the analysis time was shorter with
good separation. Additionally, when the sample
injection time was longer, the peak areas of the
analytes were larger. However, in the three repeat
tests of 60 s, 70 s, and 80 s sample injection times, the
peak area RSD values of QTP, NorQTP, and 7-QTP
were 3% in 60 s, 11e12% in 70 s, and 6e7% in 80 s,
respectively. Considering the reproducibility, the
shortest injection time of the sample (60 s) was
selected as the optimal injection condition.
3.3. Analytical method
3.3.1. Selective experiment
QTP and its metabolites, NorQTP and 7-QTP,
were investigated in this study. However, it may be
necessary for a patient who has several diseases to
use multiple drugs. Thus, an experiment was performed to evaluate this method for quantifying
analytes without interference by other drugs.
Several drugs, such as Bupropion, sertraline, bromazepam, brotizolam, clonazepam, and lorazepam,
are used to treat mental disorders and have been
tested. The CE electrophergrams are shown in
Fig. 3. The results showed that bupropion and sertraline, which are weak alkali compounds, were
positively charged in the sample solution (Fig. 3 (d)
and (g)). Others, such as bromazepam, brotizolam,
clonazepam and lorazepam, had no charge or a
negative charge in the sample solution, and no peak

was observed. Additionally, peak x as the pharmaceutical excipient was speculated. Furthermore,
these ﬁndings were supported by UV absorption
spectra. The CE signals for QTP, NorQTP and 7QTP were not inﬂuenced by the selected drugs.
3.3.2. Validation
The limit of detection (LOD) was deﬁned by the
signal-to-noise ratio (S/N ¼ 3) for each analyte. In
this method, the LODs of QTP, NorQTP, and 7-QTP
were 0.25 ng/mL, 0.50 ng/mL and 1.00 ng/mL,
respectively (Table S3). The linear range of the
analytes was set at 3e120 ng/mL. Both the intraday
correlation coefﬁcients (n ¼ 3) and the interday
correlation coefﬁcients (n ¼ 5) were greater than
0.999, which implied that there was a good linear
relationship with the quantitative range on the same
day or between different days (Table S4). Three low,
medium and high concentration in the linear range
of the calibration curve were selected to evaluate the
precision and accuracy of the proposed method;
they were 5.0 ng/mL, 40.0 ng/mL and 100.0 ng/mL,
respectively. In the intraday analysis, the RSD
values of the three analytes were less than 15.11%,
and the RE values were less than 13.09%. In the
interday analysis, the RSD values were less than
13.23%, and the RE values were less than 14.05%
(Table 1). This result indicated that the established
method has good precision and accuracy.
3.3.3. FESS sensitivity enhancement
The sensitivity of the online FESS preconcentration technique and capillary zone electrophoresis
(CZE) were compared. In the FESS technique, the
concentration of three analytes was set at 50 ng/mL,
and in CZE, the concentration of three analytes was
set at 1 mg/mL. The formula for the sensitivity
improvement is shown in Eq. (1):
Sensitivity enhancement ¼

Peak areaFESS CCZE

Peak areaCZE CFESS
ð1Þ

Fig. 3. Electropherogram of selective experiment in standard solution.
(a) blank; QTP, NorQTP and 7-QTP with (b) Bromazepam, (c) Brotizolam, (d) Bupropion, (e) Clonazepam, (f) Lorazepam, (g) Sertraline.
Analyte concentrations: peak 1: NorQTP (50 ng/mL), peak 2: QTP
(50 ng/mL), peak 3: 7-QTP (50 ng/mL), peak 4: Bupropion (200 ng/mL),
peak 5: Sertraline (800 ng/mL), peak x: Excipient. Other conditions were
shown in Fig. 2.

Peak area FESS: the peak area of analytes by
FESS.
Peak area CZE: the peak area of analytes by CZE.
C CZE: the concentration of analytes by CZE.
C FESS: the concentration of analytes by FESS.
The electropherograms of CZE and FESS are
shown in Fig. S7. After preconcentration of the three
analytes, the sensitivity enhancements were calculated by Eq. (1). The increase in sensitivity of QTP,
NorQTP and 7-QTP was 463-fold, 523-fold and 835fold, respectively. The LODs in this study were superior to those of previously published CE and

Table 1. Precision and accuracy analysis for intra-day (n¼3) and interday (n¼5) analysis of Quetiapine and its metabolites.
Concentration (ng/mL)

QTP
5
40
100
NorQTP
5
40
100
7-QTP
5
40
100

Intraday (n¼3)
a

Interday (n¼5)

RSD (%)

RE (%)

RSD (%)

REa (%)

2.47
3.42
2.53

0.01
1.97
11.96

11.25
5.10
13.23

-2.16
4.99
11.72

2.51
2.99
3.18

-1.11
4.37
13.09

6.74
5.44
6.71

-3.70
8.76
13.79

15.11
1.05
4.78

0.13
0.15
0.00

6.12
2.29
10.36

-8.85
14.05
10.94

a

RE:(concentration found-concentration known)/(concentration known)*100.

HPLC methods [9,10]. Therefore, this study combined the LLE method with the online preconcentration technique to analyze QTPs and metabolites
with the advantage of enhanced sensitivity.
3.4. Application
The analytical method established in this study
was applied to the determination of plasma samples
from a schizophrenia patient who was using QTP.
Plasma samples were collected from a male patient
(58 years old, 88.9 kg) who continued taking Seroquel® (containing QTP/300 mg). A dose of 300 mg of
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QTP was administered once after dinner every day.
Moreover, this patient also used ranitidine/150 mg,
dimethylpolysiloxane/40 mg, domperidone/10 mg,
zolpidem/10 mg, acetylsalicylic acid/100 mg, atorvastatin/40 mg, propafenone/150 mg, ramipril/
10 mg, amlodipine/5 mg, ﬂunitrazepam/1 mg, and
duloxetine/30 mg. The plasma sample was collected
1 h after taking the QTP. The electropherograms are
shown in Fig. 4 and the peaks of the QTP, NorQTP
and 7-QTP were observed. In the CE analysis, the
ratios of the peak areas of analytes and the peak
areas of the internal standard was calculated by the
calibration curve equation. Finally, the concentrations of QTP, NorQTP and 7-QTP in actual patients
were 26.09 ± 0.18 ng/mL, 60.82 ± 0.17 ng/mL, and
5.29 ± 0.08 ng/mL, respectively. The sample was also
analyzed by nano-UPLC-MS was to determine
whether QTP and its metabolites were present.
Although QTP, NorQTP and 7-QTP cannot be
separated by nano-UPLC in present condition,
MRM mode was successfully used to identify the
QTP at 384.17 (m/z), NorQTP at 296.12 (m/z) and 7QTP at 400.16 (m/z) (Fig. S8). The results were
conﬁrmed by the nano-UPLCeMS, which produced
the same results.

4. Conclusions
In this study, the pretreatment technique and LLE
were used to extract analytes and remove interference in plasma. The online pre-concentration
method FESS was applied to improve the sensitivity
of this assay. The validated method was rapid and
had better sensitivity than the traditional CE mode;
the new method can improve sensitivity 463-835fold. The LODs of QTP, NorQTP and 7-QTP were
0.5 ng/mL, 0.25 ng/mL and 1 ng/mL, respectively.
This method was also applied to a patient who was
using QTP. The concentrations of QTP, NorQTP and
7-QTP in the patient's plasma were determined,
indicating that the ﬁndings could be used to evaluate the basis of pharmacokinetics for further
establishing suitable personal medical treatments in
the future (Supporting Information can be found at
https://www.jfda-online.com/cgi/editor.cgi?article=
3378&window=additional_ﬁles&context=journal).
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